Introductory Background:

iMatrix-221MG is the clinical version of our RUO iMatrix-221.

iMatrix-221MG meets the Standards of Biological Ingredients by Pharmaceutical and Medical Devices Agency (PMDA), a government agency in Japanese which is analogous to the U.S. FDA. The regulation is one of the strictest in the world and iMatrix-221MG not only fulfills regulatory requirements, it is being implemented by numerous pharmaceutical and therapeutic companies, big and small, as well as institutes.

iMatrix-221MG is a recombinant human laminin-221 E8 fragment protein expressed in cGMP-grade Chinese Hamster Ovary (CHO)-S cells. iMatrix-221 contains the integrin-binding site of the laminin-221 molecule. iMatrix-221 is a useful cell culture substrate for proliferation and differentiation of cardiomyocytes and skeletal muscule cells. iMatrix-221MG is also useful for the culture of other cells adhering to laminin-221.



This product is exclusively sold direct from Matrixome, Inc. For sales outside of Japan, please email us by using our contact form for more information.

We ship directly anywhere in the world!

Japan to your lab in a blink of an eye. A top tier product requires a top tier shipping company. With World Courier as our exclusive shipping and logistics provider, your products will arrive quickly (usually within 24-48 hours*) and safely (with each shipment is in a temperature controlled and monitored environment).


iMatrix-221MG is not intended to diagnose, treat, cure or prevent any disease. This product is not a medical device.